BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9573281)

  • 1. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.
    van 't Wout AB; Blaak H; Ran LJ; Brouwer M; Kuiken C; Schuitemaker H
    J Virol; 1998 Jun; 72(6):5099-107. PubMed ID: 9573281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    Cornelissen M; Mulder-Kampinga G; Veenstra J; Zorgdrager F; Kuiken C; Hartman S; Dekker J; van der Hoek L; Sol C; Coutinho R
    J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
    van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
    J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    Connor RI; Ho DD
    J Virol; 1994 Jul; 68(7):4400-8. PubMed ID: 7515972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure.
    Shiino T; Kato K; Kodaka N; Miyakuni T; Takebe Y; Sato H
    J Virol; 2000 Feb; 74(3):1069-78. PubMed ID: 10627516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses.
    Peeters M; Vincent R; Perret JL; Lasky M; Patrel D; Liegeois F; Courgnaud V; Seng R; Matton T; Molinier S; Delaporte E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):115-21. PubMed ID: 10048897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS.
    Ida S; Gatanaga H; Shioda T; Nagai Y; Kobayashi N; Shimada K; Kimura S; Iwamoto A; Oka S
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1597-609. PubMed ID: 9430252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency viruses during primary infection.
    Rodrigo AG
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1447-51. PubMed ID: 9390743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivo.
    van 't Wout AB; Ran LJ; Nijhuis M; Tijnagel JM; de Groot T; van Leeuwen R; Boucher CA; Schuitemaker H; Schuurman R
    AIDS; 1998 Jul; 12(10):1169-76. PubMed ID: 9677166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection.
    Koot M; van 't Wout AB; Kootstra NA; de Goede RE; Tersmette M; Schuitemaker H
    J Infect Dis; 1996 Feb; 173(2):349-54. PubMed ID: 8568295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
    de Jong JJ; Goudsmit J; Keulen W; Klaver B; Krone W; Tersmette M; de Ronde A
    J Virol; 1992 Feb; 66(2):757-65. PubMed ID: 1731110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1.
    Connor RI; Paxton WA; Sheridan KE; Koup RA
    J Virol; 1996 Dec; 70(12):8758-64. PubMed ID: 8971004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 populations in blood and semen.
    Delwart EL; Mullins JI; Gupta P; Learn GH; Holodniy M; Katzenstein D; Walker BD; Singh MK
    J Virol; 1998 Jan; 72(1):617-23. PubMed ID: 9420266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.
    Hogervorst E; de Jong J; van Wijk A; Bakker M; Valk M; Nara P; Goudsmit J
    J Virol; 1995 Oct; 69(10):6342-51. PubMed ID: 7666535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
    Kuiken CL; de Jong JJ; Baan E; Keulen W; Tersmette M; Goudsmit J
    J Virol; 1992 Jul; 66(7):4622-7. PubMed ID: 1602564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D.
    Zhong P; Peeters M; Janssens W; Fransen K; Heyndrickx L; Vanham G; Willems B; Piot P; van der Groen G
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):239-48. PubMed ID: 7742038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
    Abebe A; Demissie D; Goudsmit J; Brouwer M; Kuiken CL; Pollakis G; Schuitemaker H; Fontanet AL; Rinke de Wit TF
    AIDS; 1999 Jul; 13(11):1305-11. PubMed ID: 10449282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.